cotrim forte heumann
heumann pharma gmbh & co. generica kg (8120809) - trimethoprim; sulfamethoxazol - tablette - teil 1 - tablette; trimethoprim (02894) 160 milligramm; sulfamethoxazol (02895) 800 milligramm
yervoy
bristol-myers squibb pharma eeig - ipilimumab - melanoma; carcinoma, renal cell; carcinoma, non-small-cell lung; mesothelioma, malignant; colorectal neoplasms - antineoplastische mittel - melanomayervoy as monotherapy or combination with nivolumab is indicated for the treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older (see section 4. yervoy in combination with nivolumab is indicated for the treatment of advanced (unresectable or metastatic) melanoma in adults. relative to nivolumab monotherapy, an increase in progression-free survival (pfs) and overall survival (os) for the combination of nivolumab with ipilimumab is established only in patients with low tumour pd-l1 expression (see sections 4. 4 und 5. renal cell carcinoma (rcc)yervoy in combination with nivolumab is indicated for the first-line treatment of adult patients with intermediate/poor-risk advanced renal cell carcinoma (see section 5. non-small cell lung cancer (nsclc)yervoy in combination with nivolumab and 2 cycles of platinum-based chemotherapy is indicated for the first-line treatment of metastatic non-small cell lung cancer in adults whose tumours have no sensitising egfr mutation or alk translocation. malignant pleural mesothelioma (mpm)yervoy in combination with nivolumab is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma. mismatch repair deficient (dmmr) or microsatellite instability-high (msi-h) colorectal cancer (crc)yervoy in combination with nivolumab is indicated for the treatment of adult patients with mismatch repair deficient or microsatellite instability-high metastatic colorectal cancer after prior fluoropyrimidine based combination chemotherapy (see section 5. oesophageal squamous cell carcinoma (oscc)yervoy in combination with nivolumab is indicated for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma with tumour cell pd-l1 expression ≥ 1%.
cefuroxim 125 heumann saft
heumann pharma gmbh & co. generica kg (8120809) - cefuroximaxetil - granulat zur herstellung einer suspension zum einnehmen - teil 1 - granulat zur herstellung einer suspension zum einnehmen; cefuroximaxetil (23006) 150,36 milligramm
olanzapin heumann 20 mg überzogene tabletten
heumann pharma gmbh & co. generica kg (8120809) - olanzapin - überzogene tablette - teil 1 - überzogene tablette; olanzapin (26581) 20 milligramm
olanzapin heumann 15 mg überzogene tabletten
heumann pharma gmbh & co. generica kg (8120809) - olanzapin - filmtablette - teil 1 - filmtablette; olanzapin (26581) 15 milligramm
gastrosil akut tropfen
heumann pharma gmbh & co. generica kg (8120809) - metoclopramidhydrochlorid (ph.eur.) - tropfen zum einnehmen, lösung - teil 1 - tropfen zum einnehmen, lösung; metoclopramidhydrochlorid (ph.eur.) (10700) 5,97 milligramm
isdn 40 retard heumann
heumann pharma gmbh & co. generica kg (8120809) - isosorbiddinitrat - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; isosorbiddinitrat (05595) 40 milligramm
isdn 20 retard heumann
heumann pharma gmbh & co. generica kg (8120809) - isosorbiddinitrat - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; isosorbiddinitrat (05595) 20 milligramm
acemetacin 30 heumann
heumann pharma gmbh & co. generica kg (8120809) - acemetacin - hartkapsel - teil 1 - hartkapsel; acemetacin (16567) 30 milligramm
lamotrigin heumann 5 mg dispers
heumann pharma gmbh & co. generica kg (8120809) - lamotrigin - tablette zur herstellung einer suspension zum einnehmen - teil 1 - tablette zur herstellung einer suspension zum einnehmen; lamotrigin (23895) 5 milligramm